Verastem, Inc., (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today reported financial results for the year ended December 31, 2013, and also commented on corporate accomplishments and plans.
"In 2013, Verastem achieved critical milestones in our mission to bring new therapies targeting cancer stem cells to patients," said Robert Forrester, President and Chief Executive Officer of Verastem.
Help employers find you! Check out all the jobs and post your resume.
